会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 46. 发明授权
    • Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
    • 丙型肝炎病毒基因型序列及其作为预防,治疗和诊断剂的用途
    • US07129337B1
    • 2006-10-31
    • US08836075
    • 1995-10-23
    • Geert MaertensLieven Stuyver
    • Geert MaertensLieven Stuyver
    • C12Q1/68C07H21/02A61K39/29
    • C07K14/005A61K38/00A61K39/00A61K2039/525C12N2770/24222
    • The present invention relates to new genomic nucleotide sequences and amino acid sequences corresponding to the coding region of these genomes. The invention relates to new HCV types and subtypes sequences which are different from the known HCV types and subtypes sequences. More particularly, the present invention relates to new HCV type 7 sequences, new HCV type 9 sequences, new HCV type 10 and new HCV type 11 sequences. Also, the present invention relates to new HCV type 1 sequences of subtypes 1d, 1e, 1f and 1g; new HCV type 2 sequences of subtypes 2e, 2f, 2g, 2h, 2i, 2k and 2l; new HCV type 3 sequences of subtype 3g, new HCV type 4 sequences of subtypes 4k, 4l and 4m; a process for preparing them, and their use for diagnosis, prophylaxis and therapy. More particularly, the present invention provides new type-specific sequences of the Core, the E1 and the NS5 regions of new HCV types 7, 9, 10 and 11, as well as of new variants (subtypes) of HCV types 1, 2, 3 and 4. These new HCV sequences are useful to diagnose the presence of HCV type 1, and/or type 2, and/or type 3, and/or type 4, and/or type 7, and/or type 9, and/or type 10, and/or type 11 genotypes or serotypes in a biological sample. Moreover, the availability of these new type-specific sequences can increase the overall sensitivity of HCV detection and should also prove to be useful for prophylactic and therapeutic purposes.
    • 本发明涉及对应于这些基因组的编码区的新的基因组核苷酸序列和氨基酸序列。 本发明涉及与已知的HCV类型和亚型序列不同的新的HCV类型和亚型序列。 更具体地,本发明涉及新的HCV 7型序列,新型HCV 9型序列,新型HCV 10型和新型HCV 11型序列。 此外,本发明涉及新型的1型,1e型,1型和1型的HCV型1型序列; 亚型2e,2f,2g,2h,2i,2k和2l的新HCV 2型序列; 亚型3g的新HCV 3型序列,亚型4k,4l和4m的新型HCV 4型序列; 它们的制备过程及其在诊断,预防和治疗中的应用。 更具体地,本发明提供新型HCV 7型,9型,10型和11型的核心,E1和NS5区域的新型特异性序列,以及HCV类型1,2和2的新变体(亚型) 这些新的HCV序列可用于诊断HCV 1型和/或2型和/或3型和/或4型和/或7型和/或9型的存在,以及 /或10型,和/或11型基因型或血清型。 此外,这些新型特异性序列的可用性可以提高HCV检测的总体灵敏度,并且还应证明可用于预防和治疗目的。
    • 48. 发明授权
    • Process for typing HCV isolates
    • 分离HCV分离株的方法
    • US06548244B2
    • 2003-04-15
    • US09899044
    • 2001-07-06
    • Geert MaertensLieven StuyverRudi RossauHugo Van Heuverswyn
    • Geert MaertensLieven StuyverRudi RossauHugo Van Heuverswyn
    • C12Q170
    • C12Q1/707C12Q1/6834C12Q2563/131C12Q2545/101C12Q2525/101C12Q2531/113
    • The invention relates to a process for genotyping any HCV isolate present in a biological sample, previously identified as being HCV positive, and for classifying said isolate according to the percentage of homology with other HCV isolates, comprising the steps of: contacting said sample in which the ribonucleotides or deoxyribonucleotides have been made accessible, if need be, under suitable denaturation, with at least one probe from about 10 to about 40 nucleotides, with said probe being liable to hybridize to a region being in the domain extending from nucleotide at position −291 to nucleotide at position −66 of the 5′ untranslated region of one of the HCV isolates represented by their cDNA sequences, with said numbering of position beginning with the first ATG codon of the open reading frame encoding the HCV polyprotein, or with said probe being complementary to the above-defined probes, detecting the complexes possibly formed between said probe and the nucleotide sequence of the HCV isolate to be identified.
    • 本发明涉及用于对先前鉴定为HCV阳性的生物样品中存在的任何HCV分离物进行基因分型的方法,以及根据与其它HCV分离株的同源性百分比对所述分离物进行分类的方法,包括以下步骤: 如果需要的话,核糖核苷酸或脱氧核糖核苷酸可以在合适的变性下与至少一个约10至约40个核苷酸的探针接触,所述探针易于与位置延伸的结构域延伸的区域杂交。 291到由其cDNA序列表示的HCV分离物之一的5'非翻译区的-66位的核苷酸,其中所述编号的位置开始于编码HCV多聚蛋白的开放阅读框的第一个ATG密码子,或与所述探针 与上述定义的探针互补,检测可能形成于所述探针和HCV核苷酸序列之间的复合物 分离鉴定。